The Efficacy of Procalcitonin as a Biomarker in the Management of Sepsis: Slaying Dragons or Tilting at Windmills?

Prasanna Sridharan; Ronald S Chamberlain

doi:10.1089/SUR.2012.028

The Efficacy of Procalcitonin as a Biomarker in the Management of Sepsis: Slaying Dragons or Tilting at Windmills?

Prasanna Sridharan
, Ronald S Chamberlain

Saint Barnabas Medical Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Surgical Infections
Volume	14
Issue number	6
DOIs	https://doi.org/10.1089/SUR.2012.028
State	Published - Nov 25 2013

Disciplines

Medicine and Health Sciences
Critical Care

Access to Document

10.1089/SUR.2012.028License: Unspecified

Cite this

@article{9809711037704cef9f4dac5494251e3d,

title = "The Efficacy of Procalcitonin as a Biomarker in the Management of Sepsis: Slaying Dragons or Tilting at Windmills?",

author = "Prasanna Sridharan and Chamberlain, \{Ronald S\}",

note = "Background Sepsis is defined as systemic inflammatory response syndrome (SIRS) in the context of an underlying infectious process, and is associated with high rates of morbidity and mortality, particularly when initial therapy is delayed.",

year = "2013",

month = nov,

day = "25",

doi = "10.1089/SUR.2012.028",

language = "American English",

volume = "14",